Vague Neurological Disorders

Similar documents
Vague Neurological Conditions

Evaluation of Parkinson s Patients and Primary Care Providers

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

III./3.1. Movement disorders with akinetic rigid symptoms

Parkinson s Disease. Sirilak yimcharoen

MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

Enhanced Primary Care Pathway: Parkinson s Disease

10th Medicine Review Course st July Prakash Kumar

DISORDERS OF THE NERVOUS SYSTEM

Dizziness: Neurological Aspect

Non-motor subtypes of Early Parkinson Disease in the Parkinson s Progression Markers Initiative

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Optimizing Clinical Communication in Parkinson s Disease:

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

FORM ID. Patient's Personal Details. SECTION A : Medical Record of the Patient. Name. Policy Number. NRIC/Old IC/Passport/Birth Cert/Others

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

Form B3L: UPDRS Part III Motor Examination 1

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Nicolas Bianchi M.D. May 15th, 2012

Central nervous system

CHAPTER 6 NERVOUS SYSTEM G00-G99. Presented by Jan Halloran

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

Brain and Central Nervous System Cancers

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

HISTORY TAKING ON NERVOUS SYSTEM. Dr. Amitesh Aggarwal

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

Headway Victoria Epilepsy and Parkinson s Centre

Designing patient-centered clinical trials: Results of the MDIC project to use patient preference information to design clinical trials

PARKINSON S DISEASE 馬 萬 里. Chinese character for longevity (shou) Giovanni Maciocia

What is Parkinson s disease?

IMPAIRMENT OF THE NERVOUS SYSTEM

DOC // HOW STROKES AFFECT THE BRAIN EBOOK

Identification number: TÁMOP /1/A

WELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS

Non-Motor Symptoms of Parkinson s Disease

Multiple System Atrophy

Evolution of a concept: Apraxia/higher level gait disorder. ataxia v. apraxia gait = limb apraxia. low, middle, high gait disturbance levels

Pa t h w a y s. Pa r k i n s o n s. MacMahon D.G. Thomas S. Fletcher P. Lee M. 2006

It s Always a Stroke; Except For When It s Not..

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St Petersburg, Florida

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

Review Evaluation of Residuals of Traumatic Brain Injury (R-TBI) Disability Benefits Questionnaire * Internal VA or DoD Use Only*

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

Chapter Fifteen. Neurological Disorders

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

The PD You Don t See: Cognitive and Non-motor Symptoms

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

First described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy"

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives

Biology 3201 Nervous System # 7: Nervous System Disorders

Neurology: The pilot, the AME, the FAA. John Hastings CAMA, Greensboro NC September 2017

Palladotomy and Pallidal Deep Brain Stimulation

Differential Diagnosis of Hypokinetic Movement Disorders

Index. Note: Page numbers of article titles are in boldface type.

Faculty. Joseph Friedman, MD

Evaluation and Management of Parkinson s Disease in the Older Patient

Worksheet 3: Physician Medical Information Worksheet

P20.2. Characteristics of different types of dementia and challenges for the clinician

Common Forms of Dementia Handout Package

The Neurologic Examination. John W. Engstrom, M.D. University of California San Francisco School of Medicine

The PD You Don t See: Cognitive and Non-motor Symptoms

Feil & Oppenheimer Psychological Services

The Person: Dementia Basics

Understanding Parkinson s Disease Important information for you and your loved ones

Issues for Patient Discussion

Stroke Mimics. Atlantic Canada Stroke Conference. Dr Warren Fieldus FRCP

THE NERVOUS SYSTEM FUNCTION

Case Study 2: Neurological Degenerative Disease FDA Regulatory and Clinical Background

MIGRAINE CLASSIFICATION

Disorders of the Nervous System. Disorders of the Neurological System. General Endpoints of CNS Disease. General Endpoints of CNS Disease

DBQ Initial Evaluation of Residuals of Traumatic Brain Injury (I-TBI) Disability

Covered Critical Illness Conditions Appendix Effective Date: March 1, 2010

P1: OTA/XYZ P2: ABC c01 BLBK231-Ginsberg December 23, :43 Printer Name: Yet to Come. Part 1. The Neurological Approach COPYRIGHTED MATERIAL

MULTIPLE SCLEROSIS PROFILE

What Do You Think of My Posterior?

Treatment of Parkinson s Disease: Present and Future

Notifiable Medical Conditions

Headache Assessment In Primary Eye Care

UNDERSTANDING PARKINSON S DISEASE

The role of the caregiver

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH

Motor Fluctuations in Parkinson s Disease

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

UDS version 3 Summary of major changes to UDS form packets

Moving fast or moving slow: an overview of Movement Disorders

Child Neurology Elective PL1 Rotation

Unified Parkinson Disease Rating Scale (UPDRS)

Dementia: It s Not Always Alzheimer s

Margaret Schenkman, PT, PhD, FAPTA University of Colorado, Denver Colorado

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Part I Parkinson Disease Diagnosis and Treatment

IDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS. Ettore Beghi Istituto Mario Negri, Milano ITALY

Transcription:

Vague Neurological Disorders Dr. Philip Smalley MD FRCPC SVP & Global Chief Medical Officer RGA International Rose Conference, September 17, 2015

Agenda Vague neurological symptoms associated with: Alzheimer s, Parkinson s, Stroke, Traumatic Brain Injury, Multiple Sclerosis and Migraine Headaches New definition of TIAs and its implication on the diagnosis and incidence of stroke Usual time course for recovery to assess degree of disability How to evidence these findings?

Causes of Long Term Disability Claims - 2013 Impairment New Claims Existing Claims MSK 28.6% 28.7% Nervous System 7.7% 15.2% Circulatory / CVD 8.7% 12.4% Cancer 15.1% 9.1% Mental 8.3% 7.7% Council for Disability Awareness (CDA) 2014 Report

Critical Illness Impairments Demanding Neurological Sequelae Stroke Multiple Sclerosis Coma Major Head Trauma Benign Brain Tumor Parkinson s Disease Alzheimer s Disease Bacterial Meningitis Encephalitis Motor Neuron Disease Muscular Dystrophy Blindness Deafness Paralysis Loss of speech Loss of Independence

Alzheimer s Disease Incidence Rates Doubles every 6.3 years after age 60 World Alzheimer Report 2015 Brookmeyer R et al. Alzheimers Dement. 2011;7(1):61-73

Risk Factors for Alzheimer Disease Diabetes Hypertension Obesity Depression Physical Inactivity Smoking Low education Barnes, D et al, Lancet Neurology July 19, 2011 6

Role of Our Microbiome 10X more bacteria than human cells Health and disease Obesity, Metabolic syndrome, Diabetes, Autoimmune-disease Anxiety, neuropsychiatric diseases, schizophrenia and Alzheimer Disease Hill JM et al, Front Aging Neurosci. 2014 Jun 16;6:127

Caregivers of Demented Relatives have more disability Ho, A., Collins, S., Davis, K. & Doty, M. A Look at Working-Age Caregivers Roles, Health Concerns, and Need for Support (2005)

Old Definition Questionnaires Neuropsych testing Alzheimer s Disease New Definition Biomarkers CSF exam PET scan IMPACT Make diagnosis 10 years sooner Sperling RA et al, Alzheimers Dement. 2011 May;7(3):280-92

Pathology of Parkinson s Disease (PD) Destruction of the Substantia Nigra in mid-brain

Non-motor Symptoms PD Diminished sense of smell (90% of PD) Sleep disturbance / REM Behaviour Disorder 38% develop Parkinson s Low voice volume Painful foot cramps Fatigue / Daytime sleepiness Falls Autonomic dysfunction: Constipation, Drooling, Increased sweating, Urinary frequency/urgency Male erectile dysfunction

Motor Symptoms - PD Tremor (85%) (resting, 4-6 Hz, spares head) Bradykinesia Rigidity and freezing in place Stooped, shuffling gait Decreased arm swing when walking Difficulty arising from a chair Micrographia (small handwriting) Lack of facial expression Slowed activities of daily living Difficulty turning in bed Postural instability

Mental Manifestations of PD 40-50% of PD patients get depression 50% get psychotic symptoms 20-40% get dementia If occurs < 1 year of motor PD features, then likely diagnosis is Lewy Body Disease, not PD Less common if PD onset is less than 50

Hoehn and Yahr Staging Scale Stage 1 One side, mild, not disabling Stage 2 Bilateral, minimal disability, posture and gait affected Stage 3 Significant slowing of movement, early balance problems walking and standing Stage 4 Severe symptoms, can still walk to limited extent, unable to live alone Stage 5 Invalidism complete, cannot stand or walk Hoehn, MM, Yahr, MD, Neurology 1967; 17:427

Time Spent in Each Stage Mean duration of disease 14.6 years Time spent in each stage: Diagnosis 1.5 years Maintenance 6 years Complex 5 years Palliative 2.2 years MacMahon DG et al, J Neurol. 1998 May;245 Suppl 1:S19-22

Deep Brain Stimulation Surgical pacemaker inserted in brain Improves disability in some PD patients $15,000 - $20,000

Stroke: Signs and Symptoms Depend on Location Left

Clinical Presentation Abrupt onset of focal neurological signs Deficit may remain fixed or rapidly improve or progress 10% of strokes have preceding history of one or more Transient Ischemic Attack (TIA) Seizures at the time of stroke occur in 3-5% of infarctions Headache is not common with simple stroke 18

Differential Diagnosis Transient Ischemic Attack Lasts usually 5 20 minutes Others. Seizure Hypoglycemia Migraine Multiple Sclerosis Cranial or peripheral nerve palsy Subdural hematoma

Migraine Headache ± Aura 12% of population, Female > Male, highest in 25 45 age group 19th leading reason of disability worldwide as per WHO Number of neurologic and psychiatric disorders, including epilepsy, stroke, major depression and anxiety disorder, show increased co-morbidity with migraine Headache 4-72 hours Unilateral and throbbing o 75%: Headache and no Aura o 38%: Aura with headache o 4%: Aura and no headache Aura Visual disturbances

Transient Ischemic Attack (TIA) Old Definition New Definition IMPACT Time based Definition < 24 hours Imaging based Definition 30% - 50% of TIAs actually have a related deficit TIA 28% STROKE 8.1% Easton JD et al, Stroke. 2009 Jun;40(6):2276-93

Prevalence Silent Brain Infarcts Silent strokes are common and >> symptomatic strokes Vermeer SE et al. Stroke. 2002 Jan;33(1):21-5

Stroke Prognosis At 5 years post Stroke: 71% had mild impairment (NIHSS < 5) 22.5% had dementia 33% had depression, falls or incontinence 9.4% developed seizures 15% institutionalized At 6 months post Stroke, 6% - 16% have completely recovered with Rankin Score 0 (Bruins Slot, K et al. BMJ 2008;336;376-379) Feigin VL et al, Neurology. 2010 Nov 2;75(18):1597-607

Modified Rankin Score Score 0 = No symptoms Score 1 = No significant disability despite symptoms, able to carry out all usual duties and activities Score 2 = Slight disability, unable to carry out all previous activities but able to look after own affairs without assistance Score 3 = Moderate disability, requiring some help, but able to walk without assistance Score 4 = Moderately severe disabililty, unable to walk without assistance and unable to attend to own bodily needs without assistance Score 5 = Severe disability, bedridden, incontinent and requiring constant nursing care and attention Score 6 = Dead

Stroke Recovery Course 58% of strokes reach maximum recovery by 2 weeks Neurological recover plateau s 12 weeks after a stroke Newman M. Stroke. 1972 Nov-Dec;3(6):702-10

Traumatic Brain Injury Coup / Contrecoup Injury Ropper, Allan H et al. N Engl J Med Volume 356(2):166-172 January 11, 20

Traumatic Brain Injury (TBI) Sequela Post-concussion Syndrome Memory difficulty has ranged from 4% to 59% Concussion does not cause a loss of autobiographical information, such as one s name and birth date Headache and dizziness have been as high as 90% at 1 month and approximately 25% at 1 year or more 32% of mild TBI patients have severe fatigue 6 months post TBI Focal neurological signs Seizures (20% if intracranial bleed and can be recurrent) Ropper, AH et al. N Engl J Med 2007;356(2):166-172 Stulemeijer M et al, J Neurol. 2006 Aug;253(8):1041-7

Anosmia (Loss of Smell) Occurs in 11% - 33% of TBI But 1% - 2% of population have some olfactory dysfunction Test on exam or with Evoked Response Olfactometry MRI and SPECT can be abnormal Recovery 11.3% - 23.3% return to normal < 6 months and unlikely to return to normal > 6 months Some recovery for up to 2 years

Multiple Sclerosis (MS) Slowly progressive autoimmune disease targeting myelin in the CNS First described 1868

Symptoms - MS Most common presenting symptoms are: Paresthesias (tend to resolve in 6 8 weeks) Weakness or fatiguibility Visual disturbances Bladder or sexual dysfunction Excess heat may worsen symptoms Uhthoff phenomenon

Signs / Examination - MS Scotoma, decreased acuity, colour blindness, diplopia Limb weakness but testing often does not correlate with degree of difficulty walking Ataxia, dysarthria, tremor, slow scanning speech

Mental Manifestations - MS Fatigue Seen in 72% of patients Responsible for 65% of the disability Not correlated to degree of physical disability Might respond to brief naps Apathy, lack of judgment, emotional lability, euphoria, sudden crying or forced laughter Dementia can be late symptom Depression and suicide

Relapses - MS Symptoms develop over days, peak less than a week, remain constant for 3 to 4 weeks, slowly resolve over ~ 1 month Relapses every ~1-2 years but ~5-10 new lesions per year on MRI Frequency of relapses decreases with age & duration of disease Most recovery occurs in first 3 months but can take up to a year

Types of MS Relapsing Remitting 85-90% start with RRMS More inflammatory Benign 10% of MS is benign Secondary Progressive 50% of RRMS develop Secondary Progressive MS More neurodegenerative Primary Progressive Primary Progressive MS Lack of response to immunetx

Kurtzke Expanded Disability Status Scale (EDSS) 0 = Normal exam 1 = No significant disability despite symptoms, able to perform all duties/activities 2 = Slight disability, unable to carry out all previous activities, able to look after self 3 = Moderate disability, fully ambulatory 4 = Fully ambulatory, self-sufficient, can walk 500 m without aid or rest 5 = Disability severe enough to impair full daily activities 6 = Uses cane or crutch 7 = Restricted to wheelchair 8 = Restricted to bed or chair 9 = Can still communicate and eat

Major Causes of Disability in MS Fatigue Cognitive and memory Spastic paraparesis Poor coordination Sphincter dysfunction

Median time to Disability - MS To EDSS 3 was 8-12 years To EDSS 6 was 14-28 years Time to EDSS 3 for progressive disease: Secondary progressive: 8 years Primary progressive: 3 years Pittock SJ et al, Neurology 2004;62:601-6 Degenhardt A et al. Nat Rev Neurol. 2009;5(12):672-82

Summary Ageing work force and adverse lifestyles leading to more neurological disability claims New clinical TIA definition Neurological recovery unlikely after 3 months Vague neurological symptoms are common and can be disabling psmalley@rgare.com

2015 RGA. All rights reserved. No part of this publication may be reproduced in any form without the prior permission of RGA. The information in this publication is for the exclusive, internal use of the recipient and may not be relied upon by any other party other than the recipient and its affiliates, or published, quoted or disseminated to any party other than the recipient without the prior written consent of RGA.